Product Images Levetiracetam
View Photos of Packaging, Labels & Appearance
- The following structural formula for levetiracetam USP, a single enantiomer, is ( ) (S) α ethyl 2 oxo 1-pyrrolidine acetamide, its molecular formula is C8H14N2O2 and its molecular weight is 170.21. Levetiracetam is chemically unrelated to existing antiepileptic drugs (AEDs). - levetiracetam oral solution usp 01
- Figure 1: Responder Rate (≥50% Reduction From Baseline) In Study 1 - levetiracetam oral solution usp 02
- Figure 2: Responder Rate (≥50% Reduction From Baseline) In Study 2: Period A - levetiracetam oral solution usp 03
- Figure 3: Responder Rate (≥50% Reduction from Baseline) In Study 3 - levetiracetam oral solution usp 04
- Figure 4: Responder Rate (≥ 50% Reduction From Baseline) in Study 4 - levetiracetam oral solution usp 05
- Figure 6: Responder Rate (≥ 50 % Reduction from Baseline) in PGTC Seizure Frequency per Week in Study 7 - levetiracetam oral solution usp 06
- PRINCIPAL DISPLAY PANEL - 473 mL Bottle LabelNDC 10135-0695-08LevetiracetamOral Solution, USP100 mg/mLDispense accompanyingMedication Guideto each patient.Rx only16 fl oz (473 mL) - levetiracetam oral solution usp 07
Product Label Images
The following 7 images provide visual information about the product associated with Levetiracetam NDC 10135-695 by Marlex Pharmaceuticals Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
The following structural formula for levetiracetam USP, a single enantiomer, is ( ) (S) α ethyl 2 oxo 1-pyrrolidine acetamide, its molecular formula is C8H14N2O2 and its molecular weight is 170.21. Levetiracetam is chemically unrelated to existing antiepileptic drugs (AEDs). - levetiracetam oral solution usp 01
Figure 1: Responder Rate (≥50% Reduction From Baseline) In Study 1 - levetiracetam oral solution usp 02
This appears to be a statistical report of a study on the effectiveness of Levetiracetam. It shows different percentages of effectiveness at different dosages compared to a placebo group. The asterisk indicates a statistically significant result.*
Figure 2: Responder Rate (≥50% Reduction From Baseline) In Study 2: Period A - levetiracetam oral solution usp 03
The text appears to be a table containing percentages and statistical information related to a study involving a placebo and two doses of Levetiracetam (1000 mg/day and 2000 mg/day). However, the table is incomplete and lacks context for further interpretation.*
Figure 3: Responder Rate (≥50% Reduction from Baseline) In Study 3 - levetiracetam oral solution usp 04
This is a statistical data table comparing the effectiveness of a placebo and a medication called Levetiracetam at 3000mg/day among two groups (N = 104 and N = 180). The percentages listed above may represent the success rate of treatment or the reduction in symptoms. The asterisk (*) indicates that the Levetiracetam group had a statistically significant improvement over the placebo group. The meaning behind the two symbols (& o) is not clear without further context.*
Figure 4: Responder Rate (≥ 50% Reduction From Baseline) in Study 4 - levetiracetam oral solution usp 05
This is a graphical presentation of the percentage of patients on placebo and Levetiracetam. The Levetiracetam group showed statistically significant results compared to the placebo group.*
Figure 6: Responder Rate (≥ 50 % Reduction from Baseline) in PGTC Seizure Frequency per Week in Study 7 - levetiracetam oral solution usp 06
This is a statistical report of the percentage of patients who received either a placebo or levetiracetam and their corresponding effectiveness. The percentage of patients who responded positively to levetiracetam was 72.2% while only 45.2% responded positively to placebo. The report also states that the response to levetiracetam was statistically significant compared to the placebo group.*
PRINCIPAL DISPLAY PANEL - 473 mL Bottle LabelNDC 10135-0695-08LevetiracetamOral Solution, USP100 mg/mLDispense accompanyingMedication Guideto each patient.Rx only16 fl oz (473 mL) - levetiracetam oral solution usp 07
This is a description of an oral solution drug called Levetiracetam which comes in a concentration of 100 mg/mL. The packaging contains the dosage instructions and safety warnings. The other texts seem to be either gibberish or inaccuracies.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
